Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents
Ohata, K.; Kohno, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1843-1852
1987
ISSN/ISBN: 0047-1852 PMID: 2824881 Document Number: 289460
Document emailed within 1 workday
Related Documents
Kawamura, H.; Nagano, H. 1987: Progress of therapeutic agents for asthma--1) Progress of anti-asthmatic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1830-1836Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Fujii, R. 1986: Progress in chemotherapeutic agents--trends in developing antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 805-813
Beker, I. 1971: Rifamycin: progress in development of antiviral agents Harefuah 80(6): 336-338
Newman, S.P. 1984: Therapeutic inhalation agents and devices. Effectiveness in asthma and bronchitis Postgraduate Medicine 76(5): 194-203 206-7
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Lee, K.H. 1987: Recent progress in the discovery and development of plant antitumor agents Gaoxiong Yi Xue Ke Xue Za Zhi 3(4): 234-250
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Solberg, L.A. 2005: Biologic aspects of thrombopoietins and the development of therapeutic agents Current Hematology Reports 4(6): 423-428
Lewis, N.J. 1985: The design and development of therapeutic agents for neuromuscular diseases Progress in Clinical and Biological Research 197: 105-110
Fujitani, Y. 2013: Strategy for research development of therapeutic agents for autoimmune diseases Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 57
Boos, R.; van Kampen, C.; Weede, W.; Beck, W. 1989: Nedocromil sodium therapy in asthma patients. Therapeutic effect in addition to treatment with oral theophylline and inhaled bronchodilator agents Fortschritte der Medizin 107(33): 712-716
Robinson, D.S.; Roberts, D.L.; Copp, J.E.; Schwiderski, U. 1989: Diagnostic and clinical assessment issues in the development and therapeutic evaluation of psychopharmacologic agents Psychopharmacology Bulletin 25(1): 9-15
Lumholtz, I.B. 1980: Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. other angina pectoris agents Sygeplejersken 80(20): 23
Makino, I.; Yoneda, M.; Tamasawa, N.; Takebe, K. 1987: New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(7): 1539-1546
Pollock, S.H.; Reichbaum, M.I.; Collier, B.H.; D'Souza, M.J. 1991: Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats Journal of Pharmacology and Experimental Therapeutics 258(1): 8-12
Hoff, P.M.; Pazdur, R. 1999: Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines: a novel class of oral antineoplastic agents Seminars in Oncology 26(6 Suppl 18: 52-56
Arzumanian, V.G. 2002: Minimum inhibitory concentrations of various antifungal agents against Basidiomycetes clinical isolates Antibiotiki i Khimioterapiia 47(2): 7-10
Xiong, Y.Q.; Li, B.H. 1994: Inhibitory action of chlorpromazine on intestinal movement in mice and its antagonistic agents Zhongguo Yao Li Xue Bao 15(3): 235-239